http://www.myhealthbox.eu/it/IT/farmaco/GABAVEBASSrl/CETREXIDIN/2973 CETREXIDIN Name Trade Name Country Italy CETREXIDIN DENT soluz 12FL 50M Manufacturer GABA Vebas Srl Active ingredient mastication chlorhexidine gluconate / CETRIMIDE Pharmaceutical Form MOUTHWASH Extract from the leaflet
Dosage Insert mastication a blunt needle on the syringe to be used for washing. Withdraw 10 ml of the solution mastication from the bottle. Introducing the syringe needle into the pulp chamber entrance of the channel to be treated. Start by washing the channel by applying a light pressure on the plunger of the syringe. Alternate washing with any mechanical instrumentation
Side effects that E 'possible to occur, in some cases, intolerance (stinging or irritation), however inconsequential, that does not require modification of the treatment. Against chlorhexidine and 'was reported some rare idiosyncratic.
Warnings The product 'for external use only; use, especially if prolonged, products for topical use can 'give rise to sensitization phenomena, in this case, stop the treatment. Do not use for prolonged treatment; ingestion mastication or accidental inhalation of some disinfectants can 'be serious, sometimes mastication fatal. Avoid contact with eyes. The use of chlorhexidine may 'lead to severe pigmentation (brown yellow) teeth rectified with a slightly abrasive mastication toothpaste, and language. The coloring may 'appear on both natural teeth on implants; it varies with the concentration of the active substance, and from individual to individual, being more 'evident in those who make particular mastication use of tannin-rich beverages such as tea' and red wine. E 'possible mastication in some rare cases un'alte ration momentary taste and a burning sensation of the tongue.
Related This entry was posted in Leaflets updates and tagged leaflet, CETREXIDIN, chlorhexidine gluconate / CETRIMIDE, mastication Mouthwash, leaflet, GABA Vebas Srl, Italy by Roberto Lattuada. Bookmark the permalink.
Connecting to% s
% D bloggers like this:
No comments:
Post a Comment